The changes are intended to reduce administrative burdens that block Medicare beneficiaries’ timely access to innovative products and to create a more predictable path for Medicare payment, CMS Administrator Seema Verma said in an announcement.
Three specific actions CMS is proposing to streamline and accelerate Medicare coverage, payment and coding for new technologies:
1. Cover external infusion pumps as DME under Medicare Part B in cases where assistance from a skilled home infusion therapy supplier is necessary for safe infusion in the home.
2. Classify all continuous glucose monitors — not just limited to therapeutic ones — as DME, establishing payment amounts for these items as well as related supplies and accessories.
3. Pay more for durable medical equipment, prosthetics, orthotic devices and supplies from suppliers in rural and non-contiguous areas.
Click here for more information on the proposed rule.
More articles on devices:
Centinel Spine patient access program to boost reimbursement support for Prodisc L
OrthoNY opens flagship location — 5 facts
Titan Medical hits $10M technical milestone under Medtronic agreement
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
